title: [Treatment of chronic inflammatory bowel disease based on evidence and according to stage: top down].
authors.affiliation: Medizinische Klinik 1, Universitätsklinikum, Universität Erlangen-Nürnberg.
authors.forename: J
authors.initials: J
authors.lastname: Mudter
authors.forename: M F
authors.initials: MF
authors.lastname: Neurath
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects; D001688:Biological Products / Q000008:administration & dosage* / Q000009:adverse effects; D003093:Colitis, Ulcerative / Q000145:classification* / Q000188:drug therapy*; D003424:Crohn Disease / Q000145:classification* / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D061345:Early Medical Intervention; D019317:Evidence-Based Medicine; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000069285:Infliximab; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D001688:Biological Products; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine; D008727:Methotrexate